BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, Inc. (OTCBB: CSDT), has released a letter to shareholders from Chairman and founder, Daniel L. Farkas, Ph.D. In the letter, Dr. Farkas introduces the Company’s proprietary technology and its plans to develop a line of next-generation medical diagnostic devices in the field of cancer and for other medical needs:
